I

Ironwood Pharmaceuticals
D

IRWD

0.75970
USD
0.03
(3.81%)
مغلق
حجم التداول
14,600
الربح لكل سهم
1
العائد الربحي
-
P/E
-4
حجم السوق
122,934,539
أصول ذات صلة
ALNY
ALNY
-4.39
(-1.33%)
325.26 USD
AMGN
AMGN
1.79
(0.60%)
298.52 USD
C
CRBP
-0.15750
(-2.03%)
7.60000 USD
GILD
GILD
-0.760
(-0.68%)
110.760 USD
NVS
NVS
-1.350
(-1.09%)
122.490 USD
S
SGMO
0.00200
(0.38%)
0.53200 USD
المزيد
الأخبار المقالات

العنوان: Ironwood Pharmaceuticals

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses,commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.